|国家科技期刊平台
首页|期刊导航|中国实用神经疾病杂志|脊髓小脑性共济失调2两家系致病基因及临床特点

脊髓小脑性共济失调2两家系致病基因及临床特点OACSTPCD

Pathogenic genes and clinical characteristics of spinocerebellar ataxia 2 in two families

中文摘要英文摘要

目的 分析洛阳地区两个脊髓小脑性共济失调(SCAs)家系的致病基因及临床特点.方法 收集先证者及其家系成员的临床资料.提取外周静脉血DNA,采用聚合酶链反应(PCR)结合琼脂糖凝胶电泳技术对两个家系先证者进行SCA1、2、3、6、7、12、17和DRPLA亚型的筛选.亚型初步确定后对目的片段进行Sanger测序,得到确认后对家系其他成员进行验证.结果 家系1和家系2先证者经检测均为SCA2亚型,致病等位基因CAG重复次数分别为44和38次,随后的家系验证结果显示家系1中检测到致病基因携带者3人,家系2中检测到致病基因携带者1人.先证者均以行走不稳为主要症状,部分成员伴言语不清、记忆力下降.结论 联合应用PCR和Sanger测序方法确诊了洛阳地区两个SCA2家系,家族性的行走不稳是其主要临床特点.

Objective To analyze the pathogenic genes and clinical characteristics of spinocerebellar ataxias(SCAs)in two pedigrees in Luoyang.Methods Clinical data of the proband and pedigree members were collected.After peripheral venous blood DNA was extracted,polymerase chain reaction(PCR)and agarose gel electrophoresis were used to screen SCA1,2,3,6,7,12,17 and DRPLA subtypes in the two probands.Sanger sequencing was performed on the target subtypes after the preliminary determination of the subtypes.After confirmation,other members of the pedigree were verified.Results The probands of family 1 and family 2 were all subtype SCA2,and the repeat times of CAG in pathogenic allele were 44 and 38,respectively.The subsequent family verification showed that there were 3 pathogenic gene carriers in pedigree 1 and 1 pathogenic gene carrier in pedigree 2.All the probands had walking instability as the main symptom,and some of them had slurred speech and memory deterioration.Conclusion Two SCA2 pedigrees in Luoyang were diagnosed by combined PCR and Sanger sequencing.Familial walking instability is the main clinical feature.

周海涛;牛宇杰;刘德全;潘社红;任向阳;李玉林;王云龙

郑州大学附属洛阳中心医院,河南 洛阳 471009||郑州大学附属洛阳中心医院中心实验室,河南 洛阳 471009||河南省肿瘤细胞免疫与再生医学国际联合实验室,河南 洛阳 471009郑州大学附属洛阳中心医院中心实验室,河南 洛阳 471009||河南省肿瘤细胞免疫与再生医学国际联合实验室,河南 洛阳 471009郑州大学附属洛阳中心医院,河南 洛阳 471009洛阳市第九人民医院,河南 洛阳 471009河南省生物工程技术研究中心,河南 郑州 450001

临床医学

脊髓小脑性共济失调聚合酶链反应Sanger测序SCA2亚型临床特点行走不稳

Spinocerebellar ataxiaPolymerase chain reactionSanger sequencingSubtype SCA2Clinical characteristicsWalking instability

《中国实用神经疾病杂志》 2024 (001)

15-19 / 5

河南省重点研发与推广专项(编号:222102310113);洛阳市科技发展计划项目(编号:2101042A)

10.12083/SYSJ.221812

评论